Key result
Interventions for type 2 diabetes, hypertension, and dyslipidaemia in the Caribbean showed significant improvements in HbA1c in only 4 of 8 studies (50%) and blood pressure in 5 of 12 studies (42%).
Why the study?
To evaluate published interventions aimed at improving the management of type 2 diabetes, hypertension, and dyslipidaemia in the Caribbean.
Do interventions aimed at improving management improve clinical outcomes (HbA1c, blood pressure, BMI) in adults with type 2 diabetes, hypertension, or dyslipidaemia in the Caribbean?
Systematic Review
Yes
Do interventions aimed at improving management improve clinical outcomes (HbA1c, blood pressure, BMI) in adults with type 2 diabetes, hypertension, or dyslipidaemia in the Caribbean?
There is currently insufficient high-quality evidence regarding effective interventions for managing type 2 diabetes, hypertension, and dyslipidaemia in the Caribbean.
Insufficient evidence supports broad adoption of studied interventions; leaves open identification of effective, region-specific strategies.
OBJECTIVE: To evaluate published interventions aimed at improving the management of type 2 diabetes, hypertension and dyslipidaemia in the Caribbean. METHODS: We conducted a systematic review of four databases in accordance with PRISMA guidelines. Inclusion criteria were conducted in the Caribbean among adults ≥ 18 years who had type 2 diabetes, hypertension or dyslipidaemia; controlled trials, interventions, or comparative studies with pre-post designs and reported on at least one of the clinical outcomes of interest. RESULTS: Seventeen studies met the criteria for inclusion. The majority were conducted in Cuba and Trinidad and Tobago, and 35% were conducted over 10 years ago. Samples were small and largely consisted of older adult females and patients with type 2 diabetes. Four of eight (50%) studies that reported on HbA1c, 5 of 12 (42%) that reported on blood pressure and 2 of 7 (29%) that reported on body mass index observed significant improvements. Study heterogeneity precluded our ability to conduct a meta-analysis. The overall quality of evidence based on GRADE criteria was low for all outcomes assessed. CONCLUSION: There is insufficient evidence on interventions to address type 2 diabetes, hypertension and dyslipidaemia in the Caribbean.
No takes yet. Share an insight, caveat, or question.
Persaud‐Lachhman et al. (2019) conducted a systematic review in Type 2 diabetes, hypertension and dyslipidaemia. Interventions for type 2 diabetes, hypertension and dyslipidaemia was evaluated on HbA1c, blood pressure, and body mass index. Interventions for type 2 diabetes, hypertension, and dyslipidaemia in the Caribbean showed significant improvements in HbA1c in only 4 of 8 studies (50%) and blood pressure in 5 of 12 studies (42%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: